NeuroOne Medical Technologies Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2024 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2024 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2024 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q1 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2026 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2026 | 1 | -$0.04 | -$0.04 | -$0.04 |
NeuroOne Medical Technologies Corporation Earnings Date And Information
NeuroOne Medical Technologies Corporation last posted its earnings results on Tuesday, May 14th, 2024. The company reported $-0.11 earnings per share for the quarter, missing analysts' consensus estimates of $-0.1 by $0.01. The company had revenue of 825,776 for the quarter and had revenue of 1.95 M for the year. NeuroOne Medical Technologies Corporation has generated $-1 earnings per share over the last year ($-0.65 diluted earnings per share) and currently has a price-to-earnings ratio of -1.58. NeuroOne Medical Technologies Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 12th, 2024 based on prior year's report dates.
NeuroOne Medical Technologies Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2024 | Q3 2024 | -$0.10 | $1.50 M | $825,776 | ||
| 05/14/2024 | Q2 2024 | -$0.10 | -$0.11 | -0.01 | $1.38 M | |
| 02/13/2024 | Q1 2024 | -$0.14 | -$0.14 | 0 | $977,649 | |
| 12/15/2023 | Q4 2023 | -$0.13 | $800,000 | $741,780 | ||
| 08/14/2023 | Q3 2023 | -$0.20 | -$0.20 | 0 | $339,500 | $629,906 |
| 05/12/2023 | Q2 2023 | -$0.21 | $466,176 | |||
| 02/13/2023 | Q1 2023 | -$0.11 | -$0.11 | 0 | $114,579 | |
| 12/21/2022 | Q4 2022 | -$0.11 | -$0.08 | 0.03 | $1.80 M | $68,788 |
| 08/11/2022 | Q3 2022 | -$0.22 | -$0.17 | 0.05 | $32,049 | |
| 05/12/2022 | Q2 2022 | -$0.20 | -$0.19 | 0.01 | $36,584 | |
| 02/14/2022 | Q1 2022 | -$0.18 | -$0.18 | 0 | $33,748 | |
| 12/15/2021 | Q4 2021 | -$0.22 | $50,000 | $48,336 | ||
| 08/13/2021 | Q3 2021 | -$0.25 | $40,096 | |||
| 05/14/2021 | Q2 2021 | -$0.21 | $18,240 | |||
| 02/16/2021 | Q1 2021 | -$0.26 | $71,474 | |||
| 12/08/2020 | Q4 2020 | -$0.08 | $1.93 M | |||
| 08/13/2020 | Q3 2020 | -$1.33 | $0 | |||
| 05/14/2020 | Q2 2020 | -$0.29 | $0 | |||
| 02/14/2020 | Q1 2020 | -$1.02 | $0 | |||
| 12/20/2019 | Q4 2019 | -$0.30 | $0 |
NeuroOne Medical Technologies Corporation Earnings: Frequently Asked Questions
-
When is NeuroOne Medical Technologies Corporation's earnings date?
NeuroOne Medical Technologies Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 12th, 2024 based off last year's report dates.
-
How can I listen to NeuroOne Medical Technologies Corporation's earnings conference call?
The conference call for NeuroOne Medical Technologies Corporation's latest earnings report can be listened to online.
-
How can I read NeuroOne Medical Technologies Corporation's conference call transcript?
The conference call transcript for NeuroOne Medical Technologies Corporation's latest earnings report can be read online.
-
How much revenue does NeuroOne Medical Technologies Corporation generate each year?
NeuroOne Medical Technologies Corporation (:NMTC) has a recorded annual revenue of $1.95 M.
-
How much profit does NeuroOne Medical Technologies Corporation generate each year?
NeuroOne Medical Technologies Corporation (:NMTC) has a recorded net income of $1.95 M. NeuroOne Medical Technologies Corporation has generated $-0.65 earnings per share over the last four quarters.
-
What is NeuroOne Medical Technologies Corporation's price-to-earnings ratio?
NeuroOne Medical Technologies Corporation (:NMTC) has a price-to-earnings ratio of -1.58 and price/earnings-to-growth ratio is -0.09.
